Centuri (CTRI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
6 Apr, 2026Executive summary
Annual meeting scheduled for May 19, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by May 18, 2026.
Voting matters and shareholder proposals
Election of nine directors is on the agenda, with all nominees recommended by the board.
Advisory vote on executive compensation is included.
Proposal to approve the Employee Stock Purchase Plan.
Ratification of PricewaterhouseCoopers LLP as the independent auditor.
Other business may be addressed as appropriate during the meeting.
Board of directors and corporate governance
Nine director nominees are listed for election, including Christian I. Brown, Dustin DeMaria, Julie A. Dill, Andrew W. Evans, Karen S. Haller, Christopher A. Krummel, Anne L. Mariucci, Steven E. Nielsen, and Charles R. Patton.
Latest events from Centuri
- Record revenue, strong governance, and key shareholder votes highlight a pivotal year.CTRI
Proxy filing6 Apr 2026 - Record revenue, margin gains, and strong 2026 outlook driven by backlog and opportunity pipeline.CTRI
Q4 202525 Feb 2026 - Q2 results declined, but cost controls, backlog, and IPO proceeds support a positive outlook.CTRI
Q2 20242 Feb 2026 - Q3 revenue fell 7.1% year-over-year, but backlog hit $4.3B and guidance was reaffirmed.CTRI
Q3 202416 Jan 2026 - Q4 revenue up 7.8%, full-year at $2.64B, with 2025 guidance targeting up to $2.8B.CTRI
Q4 202423 Dec 2025 - Registering $500M in securities and 74M-share resale, backed by long-term utility contracts.CTRI
Registration Filing16 Dec 2025 - Board recommends approval of all proxy proposals; governance and compensation practices detailed.CTRI
Proxy Filing2 Dec 2025 - Annual meeting covers director elections, say-on-pay, auditor ratification, and voting rights.CTRI
Proxy Filing2 Dec 2025 - Record Q1 bookings, margin gains, and a $4.5B backlog support a strong 2025 outlook.CTRI
Q1 202526 Nov 2025